Insider Trading › MDT › Insiders
Medtronic plc
MDT·NYSE·Insider activity
$87.09
-0.88 (-1.00%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
MDT
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
MDTS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, MDT insiders filed 0 purchases ($0) and 4 sales ($734K) on the open market, by 2 insiders. Newest filing Sep 17, 2026 (20 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by MDT insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$734KSales · 180 days
499Open-market transactions on record
2Insiders filing · 180 days
Purchases (code P) and sales (code S) of MDT common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
499 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −1,483 | $93.65 | $139K | 42.2Kdirect | Sep 16, 2026 | Sep 17, 2026 | Form 4 ↗ |
| Walter Matthew R.SVP, Chief HR Officer | Sale | −3,102 | $83.15 | $258K | 35.7Kdirect | Jul 8, 2026 | Jul 9, 2026 | Form 4 ↗ |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −228 | $80.45 | $18K | 37.2Kdirect | Jun 8, 2026 | Jun 9, 2026 | Form 4 ↗ |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −3,961 | $80.44 | $319K | 37.5Kdirect | Jun 8, 2026 | Jun 9, 2026 | Form 4 ↗ |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −385 | $97.82 | $38K | 32.8Kdirect | Feb 19, 2026 | Feb 26, 2026 | Form 4 ↗ |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −668 | $97.83 | $65K | 33.2Kdirect | Feb 19, 2026 | Feb 26, 2026 | Form 4 ↗ |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −19.3K | $97.77 | $1.9M | 33.8Kdirect | Feb 19, 2026 | Feb 26, 2026 | Form 4 ↗ |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −30.6K | $97.66 | $3.0M | 53.1Kdirect | Feb 19, 2026 | Feb 26, 2026 | Form 4 ↗ |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −1,648 | $97.86 | $161K | 83.6Kdirect | Feb 19, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | −500 | $102.08 | $51K | 46.0Kdirect | Nov 19, 2025 | Nov 21, 2025 | Form 4 ↗ |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | −325 | $102.06 | $33K | 46.5Kdirect | Nov 19, 2025 | Nov 21, 2025 | Form 4 ↗ |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | −227 | $102.05 | $23K | 46.8Kdirect | Nov 19, 2025 | Nov 21, 2025 | Form 4 ↗ |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | −825 | $102.04 | $84K | 47.1Kdirect | Nov 19, 2025 | Nov 21, 2025 | Form 4 ↗ |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | −1,995 | $102.03 | $204K | 47.9Kdirect | Nov 19, 2025 | Nov 21, 2025 | Form 4 ↗ |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | −1,942 | $101.99 | $198K | 49.9Kdirect | Nov 19, 2025 | Nov 21, 2025 | Form 4 ↗ |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | −24.2K | $101.93 | $2.5M | 51.8Kdirect | Nov 19, 2025 | Nov 21, 2025 | Form 4 ↗ |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −200 | $91.59 | $18K | 35.6Kdirect | Sep 3, 2025 | Sep 5, 2025 | Form 4 ↗ |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sale | −8,405 | $91.58 | $770K | 35.8Kdirect | Sep 3, 2025 | Sep 5, 2025 | Form 4 ↗ |
| Jellison William RDirector | Purchase | +2,500 | $92.37 | $231K | 5,000direct | Aug 25, 2025 | Aug 25, 2025 | Form 4 ↗ |
| Jellison William RDirector | Purchase | +2,500 | $92.73 | $232K | 2,500direct | Aug 22, 2025 | Aug 25, 2025 | Form 4 ↗ |
| Wall Brett A.EVP & Pres Neuroscience | Sale | −12.4K | $90.00 | $1.1M | 41.0Kdirect | Jan 24, 2025 | Jan 27, 2025 | Form 4 ↗ |
| Wall Brett A.EVP & Pres Neuroscience | Sale | −3,000 | $80.41 | $241K | 40.7Kdirect | Jan 8, 2025 | Jan 10, 2025 | Form 4 ↗ |
| Wall Brett A.EVP & Pres Neuroscience | Sale | −6,850 | $80.41 | $551K | 43.7Kdirect | Jan 8, 2025 | Jan 10, 2025 | Form 4 ↗ |
| Martha GeoffreyChairman and CEO · Director | Sale | −1,594 | $83.82 | $134K | 143.3Kdirect | Jun 7, 2024 | Jun 11, 2024 | Form 4 ↗ |
| Martha GeoffreyChairman and CEO · Director | Sale | −17.5K | $83.76 | $1.5M | 144.9Kdirect | Jun 7, 2024 | Jun 11, 2024 | Form 4 ↗ |
| Marinaro MichaelEVP & President, Surgical OU | Sale | −854 | $83.14 | $71K | 27.9Kdirect | Apr 8, 2024 | Apr 9, 2024 | Form 4 ↗ |
| Salmon SeanEVP & President Cardiovascular | Sale | −16.0K | $85.12 | $1.4M | 48.3Kdirect | Feb 21, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Salmon SeanEVP & President Cardiovascular | Sale | −13.1K | $85.15 | $1.1M | 64.3Kdirect | Feb 21, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Salmon SeanEVP & President Cardiovascular | Sale | −1,594 | $85.06 | $136K | 77.4Kdirect | Feb 21, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Wall Brett A.EVP & Pres Neuroscience | Sale | −4,997 | $82.17 | $411K | 28.9Kdirect | Dec 19, 2023 | Dec 20, 2023 | Form 4 ↗ |
| Smith Gregory LEVP Global Ops & Supply Chain | Sale | −10.0K | $83.84 | $838K | 46.7Kdirect | Aug 23, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Wall Brett A.EVP & Pres Neuroscience | Sale | −1,000 | $83.38 | $83K | 33.6Kdirect | Aug 14, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Marinaro MichaelEVP & President, Surgical OU | Sale | −1,352 | $84.11 | $114K | 28.9Kdirect | Aug 4, 2023 | Aug 7, 2023 | Form 4 ↗ |
| Wall Brett A.EVP & Pres Neuroscience | Sale | −2,000 | $87.97 | $176K | 23.9Kdirect | Jul 14, 2023 | Jul 18, 2023 | Form 4 ↗ |
| TEN HOEDT ROBEVP and Pres. Global Regions | Sale | −3,706 | $86.58 | $321K | 43.8Kdirect | Jul 10, 2023 | Jul 12, 2023 | Form 4 ↗ |
| TEN HOEDT ROBEVP and Pres. Global Regions | Sale | −1,808 | $86.59 | $157K | 43.8Kdirect | Jul 10, 2023 | Jul 12, 2023 | Form 4 ↗ |
| Salmon SeanEVP & President Cardiovascular | Sale | −16.6K | $80.50 | $1.3M | 36.1Kdirect | Dec 13, 2022 | Dec 16, 2022 | Form 4 ↗ |
| TEN HOEDT ROBEVP and Pres. Global Regions | Sale | −2,404 | $81.54 | $196K | 43.5Kdirect | Oct 14, 2022 | Oct 17, 2022 | Form 4 ↗ |
| PARKHILL KAREN LEVP & Chief Financial Officer | Sale | −682 | $110.00 | $75K | 34.9Kdirect | Mar 18, 2022 | Mar 21, 2022 | Form 4 ↗ |
| Surface Carol ASVP, Chief HR Officer | Sale | −6,000 | $105.30 | $632K | 28.5Kdirect | Mar 11, 2022 | Mar 14, 2022 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & Pres. Medical Surgical | Sale | −7,218 | $102.04 | $737K | 39.4Kdirect | Dec 23, 2021 | Dec 27, 2021 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +5,010 | $103.26 | $517K | 108.4Kdirect | Dec 16, 2021 | Dec 17, 2021 | Form 4 ↗ |
| PARKHILL KAREN LEVP & Chief Financial Officer | Sale | −682 | $110.00 | $75K | 35.4Kdirect | Dec 6, 2021 | Dec 7, 2021 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −49.1K | $126.58 | $6.2M | 48.8Kdirect | Sep 30, 2021 | Oct 1, 2021 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −50.8K | $134.17 | $6.8M | 48.8Kdirect | Aug 31, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Salmon SeanEVP & Pres Diabetes/Cardiovasc | Sale | −7,290 | $134.09 | $978K | 33.3Kdirect | Aug 25, 2021 | Aug 26, 2021 | Form 4 ↗ |
| Salmon SeanEVP & Pres Diabetes/Cardiovasc | Sale | −21.1K | $134.08 | $2.8M | 33.3Kdirect | Aug 25, 2021 | Aug 26, 2021 | Form 4 ↗ |
| Martha GeoffreyCEO · Director | Sale | −10.1K | $132.67 | $1.3M | 95.8Kdirect | Aug 25, 2021 | Aug 26, 2021 | Form 4 ↗ |
| Martha GeoffreyCEO · Director | Sale | −1,481 | $132.67 | $196K | 95.8Kdirect | Aug 25, 2021 | Aug 26, 2021 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −4,000 | $131.52 | $526K | 48.2Kdirect | Aug 2, 2021 | Aug 4, 2021 | Form 4 ↗ |
| Martha GeoffreyCEO · Director | Sale | −11.5K | $125.29 | $1.4M | 81.9Kdirect | Jun 28, 2021 | Jun 30, 2021 | Form 4 ↗ |
| Wall Brett A.EVP & Pres Neuroscience | Sale | −115 | $123.50 | $14K | 21.6Kdirect | Jun 21, 2021 | Jun 22, 2021 | Form 4 ↗ |
| PARKHILL KAREN LEVP & Chief Financial Officer | Sale | −605 | $124.47 | $75K | 86.2Kdirect | Jun 15, 2021 | Jun 17, 2021 | Form 4 ↗ |
| Wall Brett A.EVP & Pres Neuroscience | Sale | −2,473 | $128.07 | $317K | 21.5Kdirect | Jun 1, 2021 | Jun 2, 2021 | Form 4 ↗ |
| Liddicoat John REVP & President of Americas | Sale | −34.7K | $126.65 | $4.4M | 42.6Kdirect | May 28, 2021 | Jun 1, 2021 | Form 4 ↗ |
| Martha GeoffreyCEO · Director | Sale | −9,308 | $118.83 | $1.1M | 81.9Kdirect | Apr 5, 2021 | Apr 7, 2021 | Form 4 ↗ |
| Martha GeoffreyCEO · Director | Sale | −2,404 | $118.83 | $286K | 81.9Kdirect | Apr 5, 2021 | Apr 7, 2021 | Form 4 ↗ |
| PARKHILL KAREN LEVP & Chief Financial Officer | Sale | −632 | $119.12 | $75K | 86.6Kdirect | Mar 15, 2021 | Mar 16, 2021 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEA | Sale | −7,168 | $117.98 | $846K | 43.8Kdirect | Mar 2, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Surface Carol ASVP, Chief HR Officer | Sale | −15.0K | $114.90 | $1.7M | 34.1Kdirect | Dec 28, 2020 | Dec 30, 2020 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −2,605 | $115.56 | $301K | 51.5Kdirect | Dec 22, 2020 | Dec 23, 2020 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & Pres. Medical Surgical | Sale | −10.9K | $115.46 | $1.3M | 44.9Kdirect | Dec 18, 2020 | Dec 21, 2020 | Form 4 ↗ |
| PARKHILL KAREN LEVP & Chief Financial Officer | Sale | −670 | $114.33 | $77K | 86.9Kdirect | Dec 15, 2020 | Dec 16, 2020 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −20.7K | $113.13 | $2.3M | 54.1Kdirect | Nov 9, 2020 | Nov 10, 2020 | Form 4 ↗ |
| ISHRAK OMARExecutive Chairman · Director | Sale | −763 | $108.40 | $83K | 561.0Kdirect | Oct 9, 2020 | Oct 14, 2020 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −797 | $110.00 | $88K | 54.3Kdirect | Oct 8, 2020 | Oct 9, 2020 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −19.9K | $110.00 | $2.2M | 54.3Kdirect | Oct 8, 2020 | Oct 9, 2020 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +4,607 | $108.52 | $500K | 101.7Kdirect | Oct 8, 2020 | Oct 9, 2020 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEA | Sale | −9,584 | $104.34 | $1.0M | 43.5Kdirect | Sep 23, 2020 | Sep 25, 2020 | Form 4 ↗ |
| PARKHILL KAREN LEVP & Chief Financial Officer | Sale | −702 | $107.78 | $76K | 87.4Kdirect | Sep 15, 2020 | Sep 16, 2020 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEA | Sale | −9,563 | $105.05 | $1.0M | 53.1Kdirect | Sep 9, 2020 | Sep 11, 2020 | Form 4 ↗ |
| Surface Carol ASVP, Chief HR Officer | Sale | −2,000 | $97.72 | $195K | 47.4Kdirect | May 29, 2020 | Jun 2, 2020 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Purchase | +8,771 | $113.68 | $997K | 605.2Kdirect | Feb 20, 2020 | Feb 24, 2020 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −38.6K | $113.56 | $4.4M | 71.0Kdirect | Dec 24, 2019 | Dec 26, 2019 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −1,808 | $113.66 | $205K | 71.0Kdirect | Dec 24, 2019 | Dec 26, 2019 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −2,404 | $113.60 | $273K | 71.0Kdirect | Dec 24, 2019 | Dec 26, 2019 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −3,019 | $113.63 | $343K | 71.0Kdirect | Dec 24, 2019 | Dec 26, 2019 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −5,067 | $113.64 | $576K | 74.0Kdirect | Dec 24, 2019 | Dec 26, 2019 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +5,000 | $113.29 | $566K | 95.2Kdirect | Dec 6, 2019 | Dec 9, 2019 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & President MITG | Sale | −12.6K | $110.97 | $1.4M | 52.1Kdirect | Dec 2, 2019 | Dec 3, 2019 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & President MITG | Sale | −12.9K | $110.28 | $1.4M | 64.7Kdirect | Dec 2, 2019 | Dec 3, 2019 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & President MITG | Sale | −13.2K | $110.97 | $1.5M | 77.5Kdirect | Dec 2, 2019 | Dec 3, 2019 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & President MITG | Sale | −13.5K | $110.29 | $1.5M | 90.8Kdirect | Dec 2, 2019 | Dec 3, 2019 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −3,797 | $112.07 | $426K | 188.3Kdirect | Nov 15, 2019 | Nov 18, 2019 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −25.7K | $111.31 | $2.9M | 192.1Kdirect | Nov 15, 2019 | Nov 18, 2019 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −7,367 | $110.59 | $815K | 217.8Kdirect | Nov 15, 2019 | Nov 18, 2019 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −1,202 | $109.95 | $132K | 188.3Kdirect | Nov 14, 2019 | Nov 15, 2019 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −900 | $109.52 | $99K | 188.3Kdirect | Nov 14, 2019 | Nov 15, 2019 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & President MITG | Sale | −1,964 | $109.66 | $215K | 52.1Kdirect | Nov 1, 2019 | Nov 4, 2019 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & President MITG | Sale | −3,349 | $109.11 | $365K | 54.0Kdirect | Nov 1, 2019 | Nov 4, 2019 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & President MITG | Sale | −14.7K | $109.67 | $1.6M | 52.1Kdirect | Nov 1, 2019 | Nov 4, 2019 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & President MITG | Sale | −28.4K | $109.11 | $3.1M | 66.7Kdirect | Nov 1, 2019 | Nov 4, 2019 | Form 4 ↗ |
| WHITE ROBERT JOHNEVP & President MITG | Sale | −3,762 | $109.66 | $413K | 57.9Kdirect | Nov 1, 2019 | Nov 4, 2019 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −1,202 | $109.50 | $132K | 188.3Kdirect | Nov 1, 2019 | Nov 4, 2019 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −37.8K | $109.50 | $4.1M | 188.3Kdirect | Nov 1, 2019 | Nov 4, 2019 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −100 | $108.21 | $11K | 78.8Kdirect | Sep 27, 2019 | Sep 30, 2019 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −21.3K | $107.51 | $2.3M | 78.9Kdirect | Sep 27, 2019 | Sep 30, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −423 | $107.22 | $45K | 30.8Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −14.1K | $107.41 | $1.5M | 30.8Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −595 | $107.22 | $64K | 30.8Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −19.1K | $107.41 | $2.0M | 30.8Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −852 | $107.22 | $91K | 30.8Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −27.3K | $107.28 | $2.9M | 30.8Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −321 | $107.22 | $34K | 30.8Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −10.3K | $107.31 | $1.1M | 30.8Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −10.0K | $107.09 | $1.1M | 30.8Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −4,000 | $100.31 | $401K | 52.9Kdirect | Aug 5, 2019 | Aug 6, 2019 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −6,599 | $102.02 | $673K | 56.9Kdirect | Aug 2, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −5,719 | $102.02 | $583K | 100.2Kdirect | Aug 2, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −3,438 | $101.12 | $348K | 100.1Kdirect | Jul 22, 2019 | Jul 23, 2019 | Form 4 ↗ |
| Surface Carol ASVP, Chief HR Officer | Sale | −9,000 | $97.66 | $879K | 34.2Kdirect | Jun 17, 2019 | Jun 18, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −20.9K | $97.49 | $2.0M | 42.7Kdirect | Jun 12, 2019 | Jun 14, 2019 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −31.7K | $97.49 | $3.1M | 63.6Kdirect | Jun 12, 2019 | Jun 14, 2019 | Form 4 ↗ |
| Martha GeoffreyEVP & GroupPres Restora Therap | Sale | −11.0K | $96.05 | $1.1M | 48.9Kdirect | Jun 6, 2019 | Jun 7, 2019 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEA | Sale Amended | −9,000 | $91.88 | $827K | 58.8Kdirect | May 28, 2019 | Jun 12, 2019 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEA | Sale | −9,000 | $91.88 | $827K | 58.8Kdirect | May 28, 2019 | May 29, 2019 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +10.9K | $92.40 | $1.0M | 89.9Kdirect | May 24, 2019 | May 28, 2019 | Form 4 ↗ |
| PARKHILL KAREN LEVP & Chief Financial Officer | Purchase | +3,000 | $83.87 | $252K | 83.7Kdirect | Jan 9, 2019 | Jan 9, 2019 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Purchase | +12.0K | $84.05 | $1.0M | 570.7Kdirect | Jan 9, 2019 | Jan 9, 2019 | Form 4 ↗ |
| Martha GeoffreyEVP & GroupPres Restora Therap | Sale | −49.8K | $97.93 | $4.9M | 59.2Kdirect | Sep 24, 2018 | Sep 25, 2018 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −26.2K | $96.29 | $2.5M | 62.6Kdirect | Aug 31, 2018 | Sep 5, 2018 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −47.2K | $95.88 | $4.5M | 105.4Kdirect | Aug 28, 2018 | Aug 29, 2018 | Form 4 ↗ |
| POZEN ROBERT CDirector | Sale | −3,218 | $95.94 | $309K | 61.0Kdirect | Aug 23, 2018 | Aug 24, 2018 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +2,600 | $95.88 | $249K | 76.9Kdirect | Aug 23, 2018 | Aug 23, 2018 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −145.5K | $95.50 | $13.9M | 200.2Kdirect | Aug 22, 2018 | Aug 23, 2018 | Form 4 ↗ |
| Lerman Bradley ESVP General Counsel & Corp Sec | Sale | −8,910 | $86.82 | $774K | 51.8Kdirect | Jun 11, 2018 | Jun 12, 2018 | Form 4 ↗ |
| Kuntz RichardSVP & Chief Medical & Science | Sale | −11.5K | $87.13 | $1.0M | 105.9Kdirect | Jun 8, 2018 | Jun 11, 2018 | Form 4 ↗ |
| Lenehan James TDirector | Sale | −1,306 | $83.56 | $109K | 47.0Kdirect | Mar 13, 2018 | Mar 14, 2018 | Form 4 ↗ |
| Surface Carol ASVP, Chief HR Officer | Sale | −12.5K | $78.36 | $978K | 29.5Kdirect | Mar 5, 2018 | Mar 6, 2018 | Form 4 ↗ |
| Surface Carol ASVP, Chief HR Officer | Sale | −12.0K | $78.00 | $936K | 42.0Kdirect | Mar 2, 2018 | Mar 6, 2018 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale | −78.5K | $86.21 | $6.8M | 117.1Kdirect | Jan 9, 2018 | Jan 10, 2018 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −26.2K | $85.00 | $2.2M | 65.8Kdirect | Jan 5, 2018 | Jan 8, 2018 | Form 4 ↗ |
| Hanson Bryan CEVP, President, MITG | Sale | −16.0K | $82.82 | $1.3M | 88.8Kdirect | Dec 15, 2017 | Dec 18, 2017 | Form 4 ↗ |
| Hanson Bryan CEVP, President, MITG | Sale | −16.0K | $79.02 | $1.3M | 109.1Kdirect | Nov 16, 2017 | Nov 17, 2017 | Form 4 ↗ |
| Hanson Bryan CEVP, President, MITG | Sale | −16.0K | $78.03 | $1.2M | 124.6Kdirect | Oct 16, 2017 | Oct 16, 2017 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale | −140.4K | $81.63 | $11.5M | 528.1Kdirect | Sep 15, 2017 | Sep 18, 2017 | Form 4 ↗ |
| Hanson Bryan CEVP, President, MITG | Sale | −12.0K | $88.57 | $1.1M | 136.9Kdirect | Jul 17, 2017 | Jul 18, 2017 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +5,600 | $88.90 | $498K | 71.9Kdirect | Jun 21, 2017 | Jun 21, 2017 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEA | Sale | −50.8K | $81.58 | $4.1M | 51.2Kdirect | Mar 20, 2017 | Mar 21, 2017 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale | −95.0K | $82.82 | $7.9M | 550.6Kdirect | Mar 15, 2017 | Mar 17, 2017 | Form 4 ↗ |
| HAKAMI HOOMANEVP & Group President Diabetes | Sale | −52.3K | $82.33 | $4.3M | 58.9Kdirect | Mar 2, 2017 | Mar 6, 2017 | Form 4 ↗ |
| POZEN ROBERT CDirector | Purchase | +13.7K | $73.21 | $1.0M | 67.2Kdirect | Dec 13, 2016 | Dec 14, 2016 | Form 4 ↗ |
| Lenehan James TDirector | Purchase | +2,000 | $73.27 | $147K | 40.3Kdirect | Nov 23, 2016 | Nov 23, 2016 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale | −17.1K | $86.70 | $1.5M | 107.1Kdirect | Sep 27, 2016 | Sep 28, 2016 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale | −25.2K | $86.67 | $2.2M | 124.2Kdirect | Sep 26, 2016 | Sep 28, 2016 | Form 4 ↗ |
| Powell Kendall JDirector | Sale | −7,907 | $85.45 | $676K | 26.4Kdirect | Sep 15, 2016 | Sep 19, 2016 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale | −61.9K | $84.93 | $5.3M | 565.9Kdirect | Sep 15, 2016 | Sep 19, 2016 | Form 4 ↗ |
| Hanson Bryan CEVP, President, MITG | Sale | −15.0K | $87.00 | $1.3M | 153.2Kdirect | Aug 29, 2016 | Aug 31, 2016 | Form 4 ↗ |
| Hanson Bryan CEVP, President, MITG | Sale | −15.0K | $87.00 | $1.3M | 93.7Kdirect | Jul 26, 2016 | Jul 27, 2016 | Form 4 ↗ |
| Martha GeoffreyEVP & GroupPres Restora Therap | Sale | −3,766 | $88.26 | $332K | 26.3Kdirect | Jul 15, 2016 | Jul 19, 2016 | Form 4 ↗ |
| Ellis Gary LeeEVP & Global Ops and IT | Sale | −35.5K | $88.64 | $3.1M | 180.9Kdirect | Jul 13, 2016 | Jul 14, 2016 | Form 4 ↗ |
| JACKSON SHIRLEY ADirector | Sale | −2,104 | $88.64 | $186K | 34.0Kdirect | Jul 13, 2016 | Jul 14, 2016 | Form 4 ↗ |
| Surface Carol ASVP, Chief HR Officer | Sale | −9,787 | $87.08 | $852K | 59.8Kdirect | Jul 6, 2016 | Jul 8, 2016 | Form 4 ↗ |
| Hanson Bryan CEVP, President, MITG | Sale | −15.3K | $87.11 | $1.3M | 93.7Kdirect | Jul 5, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale | −49.9K | $82.60 | $4.1M | 113.6Kdirect | Jun 3, 2016 | Jun 7, 2016 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEAC | Sale | −7,656 | $80.52 | $616K | 30.9Kdirect | Jun 1, 2016 | Jun 3, 2016 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEAC | Sale | −2,760 | $80.50 | $222K | 30.9Kdirect | Jun 1, 2016 | Jun 3, 2016 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEAC | Sale | −1,684 | $80.60 | $136K | 30.9Kdirect | Jun 1, 2016 | Jun 3, 2016 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale | −4,000 | $75.22 | $301K | 104.4Kdirect | Apr 1, 2016 | Apr 5, 2016 | Form 4 ↗ |
| JACKSON SHIRLEY ADirector | Sale | −1,238 | $75.60 | $94K | 29.8Kdirect | Mar 18, 2016 | Mar 22, 2016 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale | −1,100 | $76.90 | $85K | 600.7Kdirect | Mar 17, 2016 | Mar 21, 2016 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale | −22.7K | $76.12 | $1.7M | 601.8Kdirect | Mar 17, 2016 | Mar 21, 2016 | Form 4 ↗ |
| Hanson Bryan CEVP, President, MITG | Sale | −5,000 | $75.00 | $375K | 96.8Kdirect | Mar 4, 2016 | Mar 8, 2016 | Form 4 ↗ |
| Hanson Bryan CEVP, President, MITG | Sale | −5,000 | $76.14 | $381K | 101.8Kdirect | Feb 5, 2016 | Feb 8, 2016 | Form 4 ↗ |
| Hanson Bryan CEVP & Pres Min Invas Therapies | Sale | −5,000 | $75.00 | $375K | 106.5Kdirect | Jan 8, 2016 | Jan 11, 2016 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale | −13.7K | $78.06 | $1.1M | 108.1Kdirect | Dec 4, 2015 | Dec 8, 2015 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale Amended | −9,179 | $69.83 | $641K | 526.8Kdirect | Sep 15, 2015 | Sep 18, 2015 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale Amended | −10.8K | $69.10 | $748K | 536.0Kdirect | Sep 15, 2015 | Sep 18, 2015 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale | −20.0K | $69.43 | $1.4M | 526.8Kdirect | Sep 15, 2015 | Sep 16, 2015 | Form 4 ↗ |
| Surface Carol ASVP, Chief HR Officer | Sale | −13.7K | $75.83 | $1.0M | 67.2Kdirect | Jul 14, 2015 | Jul 16, 2015 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale Amended | −32.4K | $77.39 | $2.5M | 100.7Kdirect | Apr 6, 2015 | Apr 20, 2015 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale | −31.8K | $77.39 | $2.5M | 101.3Kdirect | Apr 6, 2015 | Apr 7, 2015 | Form 4 ↗ |
| Ellis Gary LeeEVP & Chief Financial Officer | Sale | −43.2K | $77.81 | $3.4M | 165.1Kdirect | Mar 25, 2015 | Mar 27, 2015 | Form 4 ↗ |
| TEN HOEDT ROBEVP & President EMEAC | Sale | −7,619 | $77.41 | $590K | 22.4Kdirect | Mar 18, 2015 | Mar 20, 2015 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale | −20.0K | $76.24 | $1.5M | 554.4Kdirect | Mar 13, 2015 | Mar 17, 2015 | Form 4 ↗ |
| OLEARY DENISE MDirector | Sale | −368 | $78.85 | $29K | 40.6Kdirect | Feb 26, 2015 | Mar 2, 2015 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres Restora Therap | Sale | −29.8K | $78.17 | $2.3M | 93.3Kdirect | Feb 19, 2015 | Feb 20, 2015 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres Restora Therap | Sale | −20.6K | $78.28 | $1.6M | 93.3Kdirect | Feb 18, 2015 | Feb 20, 2015 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale | −12.9K | $74.54 | $958K | 97.3Kdirect | Dec 19, 2014 | Dec 22, 2014 | Form 4 ↗ |
| JACKSON SHIRLEY ADirector | Sale | −1,102 | $74.43 | $82K | 28.4Kdirect | Dec 2, 2014 | Dec 4, 2014 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres Restora Therap | Sale | −42.9K | $73.95 | $3.2M | 98.4Kdirect | Nov 28, 2014 | Dec 1, 2014 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −370 | $64.07 | $24K | 82.1Kdirect | Oct 9, 2014 | Oct 14, 2014 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres Restora Therap | Sale | −15.4K | $64.98 | $1.0M | 111.9Kdirect | Oct 6, 2014 | Oct 7, 2014 | Form 4 ↗ |
| COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc | Sale | −571 | $65.03 | $37K | 82.4Kdirect | Oct 3, 2014 | Oct 14, 2014 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres Restora Therap | Sale | −28.0K | $63.57 | $1.8M | 128.4Kdirect | Aug 26, 2014 | Aug 27, 2014 | Form 4 ↗ |
| JACKSON SHIRLEY ADirector | Sale | −2,769 | $63.66 | $176K | 28.2Kdirect | Aug 26, 2014 | Aug 27, 2014 | Form 4 ↗ |
| Szyman Catherine MSrVP & Pres Diabetes | Sale | −29.4K | $58.79 | $1.7M | 21.6Kdirect | Apr 17, 2014 | Apr 21, 2014 | Form 4 ↗ |
| Kuntz RichardSrVP & Chief Scien, Clin, Reg | Sale | −2,512 | $60.98 | $153K | 104.7Kdirect | Apr 9, 2014 | Apr 11, 2014 | Form 4 ↗ |
| Ellis Gary LeeSrVP & Chief Financial Officer | Sale | −4,246 | $61.48 | $261K | 175.0Kdirect | Apr 1, 2014 | Apr 3, 2014 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres Restora Therap | Sale | −1,982 | $60.39 | $120K | 120.7Kdirect | Mar 28, 2014 | Mar 31, 2014 | Form 4 ↗ |
| Szyman Catherine MSrVP & Pres Diabetes | Sale | −15.0K | $59.57 | $892K | 21.5Kdirect | Mar 20, 2014 | Mar 21, 2014 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale | −10.0K | $59.12 | $591K | 607.2Kdirect | Mar 14, 2014 | Mar 17, 2014 | Form 4 ↗ |
| AYOTTE NEIL PVP Interim Gen Counsel CorpSec | Sale | −1,845 | $59.64 | $110K | 10.8Kdirect | Mar 10, 2014 | Mar 11, 2014 | Form 4 ↗ |
| AYOTTE NEIL PVP Interim Gen Counsel CorpSec | Sale Amended | −3,500 | $59.64 | $209K | 12.6Kdirect | Feb 28, 2014 | Mar 11, 2014 | Form 4 ↗ |
| AYOTTE NEIL PVP Interim Gen Counsel CorpSec | Sale | −116 | $59.54 | $7K | 10.8Kdirect | Feb 28, 2014 | Mar 3, 2014 | Form 4 ↗ |
| AYOTTE NEIL PVP Interim Gen Counsel CorpSec | Sale | −1,729 | $57.14 | $99K | 10.9Kdirect | Dec 4, 2013 | Dec 4, 2013 | Form 4 ↗ |
| ISHRAK OMARChairman & CEO · Director | Sale | −10.0K | $53.58 | $536K | 611.7Kdirect | Sep 13, 2013 | Sep 16, 2013 | Form 4 ↗ |
| Szyman Catherine MSrVP & Pres Diabetes | Sale | −57.0K | $52.60 | $3.0M | 21.2Kdirect | Aug 26, 2013 | Aug 28, 2013 | Form 4 ↗ |
| Dallas H JamesSrVP Quality, Operations, IT | Sale | −32.3K | $53.19 | $1.7M | 59.1Kdirect | Aug 22, 2013 | Aug 23, 2013 | Form 4 ↗ |
| Dallas H JamesSrVP Quality, Operations, IT | Sale | −36.3K | $52.82 | $1.9M | 91.5Kdirect | Aug 21, 2013 | Aug 22, 2013 | Form 4 ↗ |
| JACKSON SHIRLEY ADirector | Sale | −8,033 | $52.84 | $424K | 24.9Kdirect | Aug 21, 2013 | Aug 22, 2013 | Form 4 ↗ |
| Dallas H JamesSrVP Quality, Operations, IT | Sale | −69.9K | $53.72 | $3.8M | 93.1Kdirect | Jul 11, 2013 | Jul 15, 2013 | Form 4 ↗ |
| Ellis Gary LeeSrVP & Chief Financial Officer | Sale | −32.6K | $53.62 | $1.7M | 169.3Kdirect | Jul 11, 2013 | Jul 15, 2013 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres Restora Therap | Sale | −1,186 | $53.50 | $63K | 117.2Kdirect | Jul 11, 2013 | Jul 11, 2013 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres Restora Therap | Sale | −29.2K | $52.89 | $1.5M | 117.2Kdirect | Jul 10, 2013 | Jul 11, 2013 | Form 4 ↗ |
| Dallas H JamesSrVP Quality, Operations, IT | Sale | −20.6K | $52.10 | $1.1M | 91.3Kdirect | Jul 1, 2013 | Jul 2, 2013 | Form 4 ↗ |
| FINDLAY D CAMERONSrVP Gneral Counsel & Corp Sec | Sale | −75.0K | $52.20 | $3.9M | 81.0Kdirect | Jun 26, 2013 | Jun 27, 2013 | Form 4 ↗ |
| Dallas H JamesSrVP Quality, Operations, IT | Sale | −78.8K | $52.76 | $4.2M | 111.9Kdirect | Jun 19, 2013 | Jun 20, 2013 | Form 4 ↗ |
| Dallas H JamesSrVP Quality, Operations, IT | Sale | −2,789 | $52.08 | $145K | 190.7Kdirect | Jun 19, 2013 | Jun 20, 2013 | Form 4 ↗ |
| Dallas H JamesSrVP Quality, Operations, IT | Sale | −12.3K | $52.77 | $649K | 193.5Kdirect | Jun 19, 2013 | Jun 20, 2013 | Form 4 ↗ |
| Dallas H JamesSrVP Quality, Operations, IT | Sale | −200 | $52.08 | $10K | 205.8Kdirect | Jun 19, 2013 | Jun 20, 2013 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +680 | $52.32 | $36K | 4,800indirect | May 22, 2013 | May 22, 2013 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +4,120 | $52.32 | $216K | 4,120indirect | May 22, 2013 | May 22, 2013 | Form 4 ↗ |
| SCHULER JACK WDirector | Sale | −10.6K | $48.93 | $521K | 21.9Kindirect | May 10, 2013 | Jun 27, 2013 | Form 4 ↗ |
| SCHULER JACK WDirector | Sale | −10.7K | $48.93 | $523K | 21.8Kindirect | May 10, 2013 | Jun 27, 2013 | Form 4 ↗ |
| SCHULER JACK WDirector | Sale | −10.6K | $48.93 | $521K | 21.9Kindirect | May 10, 2013 | Jun 27, 2013 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +4,400 | $37.94 | $167K | 28.0Kdirect | Jun 18, 2012 | Jun 19, 2012 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +800 | $37.94 | $30K | 23.6Kdirect | Jun 18, 2012 | Jun 19, 2012 | Form 4 ↗ |
| BUTEL JEAN LUCEVP & Group Pres MDT Intl | Sale | −58.7K | $38.81 | $2.3M | 130.4Kdirect | Jan 11, 2012 | Jan 12, 2012 | Form 4 ↗ |
| SCHULER JACK WDirector | Sale | −745 | $38.52 | $29K | 32.6Kindirect | Dec 30, 2011 | Jun 27, 2013 | Form 4 ↗ |
| SCHULER JACK WDirector | Sale | −5 | $38.26 | $191 | 32.5Kindirect | Dec 30, 2011 | Jun 27, 2013 | Form 4 ↗ |
| SCHULER JACK WDirector | Sale | −770 | $38.50 | $30K | 32.5Kindirect | Dec 30, 2011 | Jun 27, 2013 | Form 4 ↗ |
| SCHULER JACK WDirector | Sale | −735 | $38.50 | $28K | 32.6Kindirect | Dec 30, 2011 | Jun 27, 2013 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +10.0K | $35.14 | $351K | 528.4Kdirect | Sep 1, 2011 | Sep 2, 2011 | Form 4 ↗ |
| Powell Kendall JDirector | Purchase | +3,000 | $35.20 | $106K | 3,000indirect | Sep 1, 2011 | Sep 2, 2011 | Form 4 ↗ |
| ANDERSON RICHARD HDirector | Purchase | +3,000 | $35.23 | $106K | 18.8Kdirect | Aug 31, 2011 | Sep 2, 2011 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres Restora Therap | Sale | −4,000 | $33.98 | $136K | 99.2Kdirect | Aug 4, 2011 | Aug 4, 2011 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +25.0K | $40.70 | $1.0M | 518.3Kdirect | May 25, 2011 | May 26, 2011 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +100.0K | $37.06 | $3.7M | 489.8Kdirect | Dec 22, 2010 | Dec 23, 2010 | Form 4 ↗ |
| Lenehan James TDirector | Purchase | +500 | $36.28 | $18K | 19.7Kdirect | Jul 6, 2010 | Jul 8, 2010 | Form 4 ↗ |
| Lenehan James TDirector | Purchase | +2,500 | $36.27 | $91K | 19.2Kdirect | Jul 6, 2010 | Jul 8, 2010 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +300 | $36.93 | $11K | 30.0Kindirect | Jun 25, 2010 | Jun 29, 2010 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +29.7K | $36.93 | $1.1M | 29.7Kindirect | Jun 25, 2010 | Jun 29, 2010 | Form 4 ↗ |
| LaNeve StephenSVP & Pres Spinal & Biologics | Sale | −1,454 | $45.33 | $66K | 42.1Kdirect | Apr 9, 2010 | Apr 13, 2010 | Form 4 ↗ |
| LaNeve StephenSVP & Pres Spinal & Biologics | Sale | −100 | $44.55 | $4K | 43.5Kdirect | Mar 26, 2010 | Mar 30, 2010 | Form 4 ↗ |
| LaNeve StephenSVP & Pres Spinal & Biologics | Sale | −323 | $44.55 | $14K | 43.6Kdirect | Mar 26, 2010 | Mar 30, 2010 | Form 4 ↗ |
| LaNeve StephenSVP & Pres Spinal & Biologics | Sale | −900 | $44.52 | $40K | 44.0Kdirect | Mar 26, 2010 | Mar 30, 2010 | Form 4 ↗ |
| LaNeve StephenSVP & Pres Spinal & Biologics | Sale | −4,809 | $44.51 | $214K | 44.9Kdirect | Mar 26, 2010 | Mar 30, 2010 | Form 4 ↗ |
| LaNeve StephenSVP & Pres Spinal & Biologics | Sale | −3,643 | $45.00 | $164K | 49.7Kdirect | Mar 26, 2010 | Mar 30, 2010 | Form 4 ↗ |
| Mackin James PSVP & Pres CRDM | Sale | −100 | $45.89 | $5K | 93.4Kdirect | Jan 11, 2010 | Jan 11, 2010 | Form 4 ↗ |
| Mackin James PSVP & Pres CRDM | Sale | −4,096 | $45.89 | $188K | 93.5Kdirect | Jan 11, 2010 | Jan 11, 2010 | Form 4 ↗ |
| Mackin James PSVP & Pres CRDM | Sale | −109 | $45.60 | $5K | 97.6Kdirect | Jan 7, 2010 | Jan 11, 2010 | Form 4 ↗ |
| Mackin James PSVP & Pres CRDM | Sale | −4,388 | $45.70 | $201K | 97.7Kdirect | Jan 7, 2010 | Jan 11, 2010 | Form 4 ↗ |
| Ellis Gary LeeSrVP & Chief Financial Officer | Sale | −19.6K | $37.01 | $726K | 133.2Kdirect | Oct 16, 2009 | Oct 20, 2009 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres S&B N D ST | Sale | −579 | $36.31 | $21K | 77.2Kdirect | Oct 5, 2009 | Oct 6, 2009 | Form 4 ↗ |
| OConnell Christopher JEVP & GroupPres S&B N D ST | Sale | −8,478 | $36.30 | $308K | 77.8Kdirect | Oct 5, 2009 | Oct 6, 2009 | Form 4 ↗ |
| OConnell Christopher JSVP & Pres Diabetes | Sale | −4,762 | $32.50 | $155K | 71.3Kdirect | May 22, 2009 | May 27, 2009 | Form 4 ↗ |
| Szyman Catherine MSrVP Strategy Innovation | Sale | −2,629 | $32.00 | $84K | 32.5Kdirect | May 22, 2009 | May 27, 2009 | Form 4 ↗ |
| Szyman Catherine MSrVP Strategy Innovation | Sale | −1,239 | $32.47 | $40K | 35.1Kdirect | May 22, 2009 | May 27, 2009 | Form 4 ↗ |
| ROSSO JEAN PIERREDirector | Purchase | +1,000 | $40.41 | $40K | 17.5Kdirect | Oct 10, 2008 | Oct 14, 2008 | Form 4 ↗ |
| OConnell Christopher JSVP & Pres Diabetes | Sale | −300 | $52.85 | $16K | 65.0Kdirect | Sep 25, 2008 | Sep 29, 2008 | Form 4 ↗ |
| OConnell Christopher JSVP & Pres Diabetes | Sale | −848 | $52.85 | $45K | 65.3Kdirect | Sep 25, 2008 | Sep 29, 2008 | Form 4 ↗ |
| LaNeve StephenSVP & Pres Spinal & Biologics | Sale | −2,010 | $52.50 | $106K | 8,875direct | Jul 11, 2008 | Jul 15, 2008 | Form 4 ↗ |
| LaNeve StephenSVP & Pres Spinal & Biologics | Sale | −2,010 | $52.25 | $105K | 10.9Kdirect | Jul 11, 2008 | Jul 15, 2008 | Form 4 ↗ |
| Szyman Catherine MSVP Strategy & Innovation | Sale | −17.8K | $52.66 | $939K | 12.2Kdirect | Jul 10, 2008 | Jul 14, 2008 | Form 4 ↗ |
| Stuge OernSr VP & Pres, Europe, EM & Can | Sale | −6,075 | $49.75 | $302K | 57.1Kdirect | May 1, 2008 | May 5, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −100 | $49.67 | $5K | 279.3Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −111 | $49.67 | $6K | 279.4Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −300 | $49.66 | $15K | 279.5Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.65 | $50K | 279.8Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −3,484 | $49.50 | $172K | 280.8Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.49 | $49K | 284.2Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −489 | $49.48 | $24K | 285.2Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −500 | $49.43 | $25K | 285.7Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −3,000 | $49.42 | $148K | 286.2Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.42 | $49K | 289.2Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.42 | $49K | 290.2Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −500 | $49.41 | $25K | 291.2Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.40 | $49K | 291.7Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −3,000 | $49.39 | $148K | 292.7Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −500 | $49.39 | $25K | 295.7Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −500 | $49.39 | $25K | 296.2Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.36 | $49K | 296.7Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −500 | $49.35 | $25K | 297.7Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,652 | $49.33 | $81K | 298.2Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −900 | $49.33 | $44K | 299.9Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.32 | $49K | 300.8Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −500 | $49.32 | $25K | 301.8Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.32 | $49K | 302.3Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −2,000 | $49.31 | $99K | 303.3Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.31 | $49K | 305.3Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −800 | $49.31 | $39K | 306.3Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −500 | $49.20 | $25K | 307.1Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −2,000 | $49.19 | $98K | 307.6Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −2,000 | $49.16 | $98K | 309.6Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.15 | $49K | 311.6Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −1,000 | $49.14 | $49K | 312.6Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| MAHLE STEPHEN HExecVP Healthcare Policy & Reg | Sale | −500 | $49.13 | $25K | 313.6Kdirect | Apr 30, 2008 | May 1, 2008 | Form 4 ↗ |
| WARD SCOTT RSrVP & Pres, CardioVascular | Sale | −32.4K | $50.00 | $1.6M | 58.5Kdirect | Apr 11, 2008 | Apr 14, 2008 | Form 4 ↗ |
| WARD SCOTT RSrVP & Pres, CardioVascular | Sale | −4,831 | $50.06 | $242K | 58.5Kdirect | Apr 10, 2008 | Apr 14, 2008 | Form 4 ↗ |
| HAWKINS WILLIAM APresident & Chief Exec Officer · Director | Purchase | +3,060 | $48.95 | $150K | 209.1Kdirect | Feb 22, 2008 | Feb 25, 2008 | Form 4 ↗ |
| Dallas H JamesSrVP & Chief Information Offcr | Purchase | +387 | $48.18 | $19K | 67.1Kdirect | Feb 22, 2008 | Feb 25, 2008 | Form 4 ↗ |
| Dallas H JamesSrVP & Chief Information Offcr | Purchase | +14.6K | $48.18 | $704K | 66.7Kdirect | Feb 22, 2008 | Feb 25, 2008 | Form 4 ↗ |
| Dallas H JamesSrVP & Chief Information Offcr | Purchase | +600 | $48.15 | $29K | 52.1Kdirect | Feb 22, 2008 | Feb 25, 2008 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +3,700 | $49.40 | $183K | 12.9Kindirect | Feb 21, 2008 | Feb 22, 2008 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +400 | $49.38 | $20K | 9,200indirect | Feb 21, 2008 | Feb 22, 2008 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +2,000 | $49.49 | $99K | 383.1Kdirect | Feb 21, 2008 | Feb 22, 2008 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +7,500 | $49.45 | $371K | 381.1Kdirect | Feb 21, 2008 | Feb 22, 2008 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +5,400 | $49.44 | $267K | 373.6Kdirect | Feb 21, 2008 | Feb 22, 2008 | Form 4 ↗ |
| SCHULER JACK WDirector | Purchase | +6,100 | $49.43 | $302K | 368.2Kdirect | Feb 21, 2008 | Feb 22, 2008 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →